# Sabra Health Care (SBRA) — Analyst Forecast

SBRA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sbra/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 6 | 10 | 0 | 16 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $20.00 | $22.20 | $25.00 | 5 |

Last price $19.29 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | Barclays | Maintained | Equal-Weight | $21.00 |
| Oct 13, 2026 | UBS | Maintained | Neutral | $20.00 |
| Aug 31, 2026 | Barclays | Maintained | Equal-Weight | $23.00 |
| Aug 31, 2026 | Baird | Maintained | Neutral | $21.00 |
| Aug 6, 2026 | Raymond James | Upgraded | Underperform → Market Perform | — |
| Jul 22, 2026 | Citizens | Maintained | Market Outperform | $25.00 |
| Jul 22, 2026 | Truist Securities | Maintained | Buy | $24.00 |
| Jul 22, 2026 | Baird | Maintained | Neutral | $23.00 |
| Jul 8, 2026 | Truist Securities | Upgraded | Hold → Buy | $22.00 |
| Jul 8, 2026 | UBS | Maintained | Neutral | $21.00 |
| Jul 7, 2026 | Barclays | Initiated Coverage | Equal-Weight | $21.00 |
| Jun 23, 2026 | Citigroup | Downgraded | Buy → Neutral | $19.00 |
| Jun 18, 2026 | Scotiabank | Maintained | Sector Perform | $19.00 |
| Jun 17, 2026 | Raymond James | Maintained | Market Perform → Underperform | — |
| Jun 1, 2026 | Wells Fargo | Maintained | Overweight | $23.00 |
| May 21, 2026 | Scotiabank | Maintained | Sector Perform | $22.00 |
| May 13, 2026 | UBS | Maintained | Neutral | $22.00 |
| May 11, 2026 | Cantor Fitzgerald | Maintained | Neutral | $22.00 |
| Mar 26, 2026 | Wells Fargo | Maintained | Overweight | $22.00 |
| Mar 13, 2026 | Truist Securities | Maintained | Hold | $22.00 |

## Frequently Asked Questions

### What is the price target for SBRA stock?

The average 12-month analyst price target for Sabra Health Care (SBRA) is $22.20, with a high estimate of $25.00 and a low of $20.00, across 5 analysts.

### Is SBRA a buy, sell, or hold?

Analysts covering Sabra Health Care currently average a Hold rating: 6 buy, 10 hold and 0 sell, from 16 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for SBRA?

The average price target of $22.20 implies 15.09% upside from the last price of $19.29.

### What is the latest analyst rating on SBRA?

On Oct 13, 2026, Barclays maintained Sabra Health Care at Equal-Weight with a price target of $21.00.

## Similar Stocks

- [OHI](https://www.lighthorse.io/tickers/ohi) — Omega Healthcare Investors, Inc. Common Stock
- [CTRE](https://www.lighthorse.io/tickers/ctre) — CareTrust REIT, Inc. Common Stock
- [NHI](https://www.lighthorse.io/tickers/nhi) — National Health Investors, Inc. Common Stock
- [LTC](https://www.lighthorse.io/tickers/ltc) — LTC Properties, Inc. Common Stock
- [VTR](https://www.lighthorse.io/tickers/vtr) — Ventas, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).